Search
Skip to Search Results- 2Carboplatin
- 2Childhood cancer
- 1Acute lymphoblastic leukemia
- 1Audiology
- 1Childhood cancer survivors
- 1Cisplatin
-
Fall 2019
The development of efficacious anticancer therapies has significantly improved the prognosis of childhood cancer patients at the price of predisposing survivors to extensive chronic health problems. Although not fatal, reducing treatment-related hearing loss (ototoxicity) among childhood cancer...
-
Inequalities by Race/Ethnicity and Socioeconomic Position in the Incidence and Survival of Childhood Acute Lymphoblastic Leukemia in the United States
DownloadFall 2015
Background: Childhood acute lymphoblastic leukemia (ALL) is the most common childhood cancer in the United States. The incidence and survival of childhood ALL have been reported to be closely associated with race/ethnicity and socioeconomic position (SEP). However, the relationship between SEP...
-
Novel mechanisms of carboplatin resistance in epithelial ovarian cancer and their therapeutic potential
DownloadFall 2015
Ovarian cancer is the fifth leading cause of cancer-related mortality in women. Epithelial ovarian cancer (EOC) constitutes approximately 90% of all ovarian malignancies. Platinum-based compounds have been used to treat EOC, with carboplatin currently being used as a first-line therapeutic agent...